Methylprednisolone acetate and Feeling jittery - a phase IV clinical study of FDA data

Summary:

Feeling jittery is reported as a side effect among people who take Methylprednisolone acetate (methylprednisolone acetate), especially for people who are female, 40-49 old, also take Sulfasalazine, and have Rheumatoid arthritis.

The phase IV clinical study analyzes which people have Feeling jittery when taking Methylprednisolone acetate. It is created by eHealthMe based on reports of 2,805 people who have side effects when taking Methylprednisolone acetate from the FDA, and is updated regularly.

What is Methylprednisolone acetate?

Methylprednisolone acetate has active ingredients of methylprednisolone acetate. eHealthMe is studying from 2,816 Methylprednisolone acetate users. Check the latest studies of Methylprednisolone acetate.

What is Feeling jittery?

Feeling jittery is found to be associated with 1,108 drugs and 1,128 conditions by eHealthMe. Check the latest studies of Feeling jittery.

On Jul, 20, 2026

2,805 people reported to have side effects when taking Methylprednisolone acetate.
Among them, 61 people (2.17%) have Feeling jittery.

Could Methylprednisolone acetate cause Feeling jittery?

Among these 61 people:

What is the gender of people who have Feeling jittery when taking Methylprednisolone acetate? *

female: 100 %
male: 0.0 %

What is the age of people who have Feeling jittery when taking Methylprednisolone acetate? *

What are other drugs people take besides Methylprednisolone acetate? *

What are other side effects people have besides Feeling jittery? *

Photophobia (extreme sensitivity to light): 61 people, 100.00%
Pleuritic Pain: 61 people, 100.00%
Atelectasis (partial or complete collapse of the lung): 61 people, 100.00%
Pain In Extremity: 61 people, 100.00%
Ocular Hyperaemia (an abnormally large amount of blood in eye): 61 people, 100.00%
Crepitations (noises are produced by the rubbing of parts one against the other): 61 people, 100.00%
Tenosynovitis Stenosans (a common disorder characterized by catching, snapping or locking of the involved finger flexor tendon, associated with dysfunction and pain): 61 people, 100.00%
Tenderness (pain or discomfort when an affected area is touched): 61 people, 100.00%
Musculoskeletal Stiffness (stiffness of the body's muscles, joints, tendons, ligaments and nerves): 61 people, 100.00%
Scleritis (inflammation of sclera): 61 people, 100.00%

What are the existing conditions these people have? *

Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 60 people, 98.36%
Inflammation: 23 people, 37.70%
Fibromyalgia (a long-term condition which causes pain all over the body): 23 people, 37.70%
Bursitis (inflammation of a bursa, typically one in the knee, elbow, or shoulder): 20 people, 32.79%
Back Pain: 20 people, 32.79%
Pain: 17 people, 27.87%
Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 7 people, 11.48%

* Approximation only. Some reports may have incomplete information.

Do you take Methylprednisolone acetate and have Feeling jittery?

- Check whether Feeling jittery is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Methylprednisolone acetate:

Methylprednisolone acetate (2,816 reports)

Feeling jittery treatments and more:

Feeling jittery (21,911 reports)

Browse all side effects of Methylprednisolone acetate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Feeling jittery:

Feeling jittery (1,109 drugs)

Browse all the conditions that are associated with Feeling jittery:

Feeling jittery (1,128 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on methylprednisolone acetate (the active ingredients of Methylprednisolone acetate) and Methylprednisolone acetate (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.